E-LIB Suche - Ergebnisse für: Simon, Peter O.

1

A phase I study of IMP321 and gemcitabine as the front-line..:

Wang-Gillam, Andrea ; Plambeck-Suess, Stacey ; Goedegebuure, Peter...
Investigational New Drugs. 31 (2012) 3 - p. 707-713 , 2012

Link: https://doi.org/10.1007/..

2

A single-institution review of 157 patients presenting with..:

Hornick, John R. ; Johnston, Fabian M. ; Simon, Peter O....
Surgery. 150 (2011) 2 - p. 169-176 , 2011

Link: https://doi.org/10.1016/..

3

The paneth cell α-defensin cryptdin 3 induces a Ca2+-depend..:

Simon, Peter O. ; Lin, Patricia ; Gerwitz, Andrew T....
Gastroenterology. 120 (2001) 5 - p. A22 , 2001

Link: https://doi.org/10.1016/..

4

S. typhimurium secretes a novel pro-inflammatory factor tha..:

Gewirtz, Andrew T. ; Simon, Peter O. ; Esterly, Denice..
Gastroenterology. 118 (2000) 4 - p. A101 , 2000

Link: https://doi.org/10.1016/..

5

Upper-Extremity Subintimal Arterial Flossing with Antegrade..:

Meuse, Michael A. ; Schenk, Amy F. ; Simon Jr., Peter O..
Journal of Vascular and Interventional Radiology. 25 (2014) 8 - p. 1306-1308 , 2014

Link: https://doi.org/10.1016/..

6

Comprehensive Review in Vascular and Endovascular Medicine:

Simon Jr, Peter O.
Journal of Vascular and Interventional Radiology. 24 (2013) 12 - p. 1899-1900 , 2013

Link: https://doi.org/10.1016/..

7

Balloon-Occluded Retrograde Transvenous Obliteration of Gas..:

Saad, Wael E. ; Simon Jr., Peter O. ; Rose, Steven C.
CardioVascular and Interventional Radiology. 37 (2013) 2 - p. 299-315 , 2013

Link: https://doi.org/10.1007/..

8

Sigma-2 receptor ligands potentiate conventional chemothera..:

Kashiwagi, Hiroyuki ; McDunn, Jonathan E ; Simon Jr, Peter O...
Journal of Translational Medicine. 7 (2009) 1 - p. , 2009

Link: https://doi.org/10.1186/..

9

Targeting AKT with the proapoptotic peptide, TAT‐CTMP: A no..:

Simon Jr., Peter O. ; McDunn, Jonathan E. ; Kashiwagi, Hiroyuki...
International Journal of Cancer. 125 (2009) 4 - p. 942-951 , 2009

Link: https://doi.org/10.1002/..

10

Targeted delivery to tumors in vivo with sigma‐2 ligands:

McDunn, Jonathan Edward ; Kashiwagi, Hiroyuki ; Vangveravong, Suwanna...
The FASEB Journal. 22 (2008) S1 - p. , 2008

Link: https://doi.org/10.1096/..

11

P31. A Pancreas Cancer Targeted AkT Inhibitor Induces Apopt..:

Simon Jr., Peter O. ; McDunn, Jonathan ; Kashiwagi, Hiroyuki...
Journal of Surgical Research. 144 (2008) 2 - p. 448 , 2008

Link: https://doi.org/10.1016/..

12

QS306. A Pancreas Cancer Targeted Akt Inhibitor Induces Apo..:

Simon Jr., Peter O. ; McDunn, Jonathan ; Kashiwagi, Hiroyuki...
Journal of Surgical Research. 144 (2008) 2 - p. 388-389 , 2008

Link: https://doi.org/10.1016/..

13

Selective sigma-2 ligands preferentially bind to pancreatic..:

Kashiwagi, Hiroyuki ; McDunn, Jonathan E ; Simon Jr, Peter O...
Molecular Cancer. 6 (2007) 1 - p. , 2007

Link: https://doi.org/10.1186/..

14

Paneth Cell Cryptdins Act in Vitro as Apical Paracrine Regu..:

Lin, Patricia W. ; Simon Jr., Peter O. ; Gewirtz, Andrew T....
Journal of Biological Chemistry. 279 (2004) 19 - p. 19902-19907 , 2004

Link: https://doi.org/10.1074/..

15

A Phase I Study of IMP321 and Gemcitabine as the Front-line..:

Wang-Gillam, Andrea ; Plambeck-Suess, Stacey ; Goedegebuure, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2012

Link: http://www.ncbi.nlm.nih...